No Detail Found!

Role of hydroxyurea in psoriasis - A review.

Author(s)
Lubna Khondker Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University, Bangladesh
Agha Masood Choudhury Department of Dermatology and Venereology, Bangabandhu Sheikh Mujib Medical University, Bangladesh
Obaidur Rahman Shah Department of Dermatology and Venereology, Combined Military Hospital, CMH, Dhaka, Bangladesh
Shirajul Islam Khan Department of Dermatology and Venereology, Combined Military Hospital, CMH, Dhaka, Bangladesh
Shahidullah Department of Dermatology and Venereology, Shaheed Monsur Ali Medical College Hospital, Dhaka, Bangladesh
Abu Reza Sayem Ahmed Directorate General of Health, Dhaka, Bangladesh
Abstract
Objectives: Most of the patients of psoriasis have a chronic course with the need for continuous control of disease activity. Patients with moderate-to-severe disease usually require phototherapy, photochemotherapy or systemic agents (e.g. cyclosporin, methotrexate, oral retinoids, fumaric acidesters) to control their disease adequately. In general these therapeutic modalities have proven to be highly effective in the treatment of psoriasis. However, potentially serious toxicity can limit their long term use. In this respect, hydroxyurea compares favourably with methotrexate which has a potential for producing irreversible hepatic damage and cyclosporin A with its potential for dose- related nephrotoxicity. Hydroxyurea, a hydroxylated molecule of urea is commonly used to treat chronic myelogeneous leukemia and polycythemia vera. Recent studies suggest it as an alternative to methotrexate in moderate-to-severe psoriasis.
Publication Details
Page(s) 257-261
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 22, Issue: 3, Year: 2012

Request the full text from PASTIC

0

Citations

0

Downloads

27

Views